Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1422142/000156459017011099/ck0001422142-10q_20170331.htm
SEC Filings
ARPO Annual Reports
10-K Annual Report March 2021
10-K Annual Report March 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report February 2015
10-K Annual Report March 2014
10-K Annual Report March 2013
10-K Annual Report March 2012
10-K Annual Report March 2021
10-K Annual Report March 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report February 2015
10-K Annual Report March 2014
10-K Annual Report March 2013
10-K Annual Report March 2012
ARPO Quarterly Reports
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report November 2018
10-Q Quarterly Report August 2018
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report November 2018
10-Q Quarterly Report August 2018
ARPO Corporate News
Bylaw Change
Change in Assets
Change in Control
Code of Ethics Change
Event for Officers
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales August 2021
Financial Exhibit
New Agreement August 2021
Vote of Security Holders August 2021
Earnings Release
Financial Exhibit August 2021
Financial Exhibit
Regulated Disclosure
Vote of Security Holders July 2021
Financial Exhibit
Regulated Disclosure June 2021
Earnings Release
Financial Exhibit May 2021
Bylaw Change
Change in Control
Event for Officers
Financial Exhibit
New Agreement
Regulated Disclosure
Unregistered Sales May 2021
Event for Officers
Financial Exhibit April 2021
Earnings Release
Financial Exhibit March 2021
Bylaw Change
Change in Assets
Change in Control
Code of Ethics Change
Event for Officers
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales
Change in Assets
Change in Control
Code of Ethics Change
Event for Officers
Financial Exhibit
New Agreement
Security Holders Change
Unregistered Sales
August 2021
Financial Exhibit
New Agreement
New Agreement
August 2021
Vote of Security Holders
August 2021
Earnings Release
Financial Exhibit
Financial Exhibit
August 2021
Financial Exhibit
Regulated Disclosure
Vote of Security Holders
Regulated Disclosure
Vote of Security Holders
July 2021
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
June 2021
Earnings Release
Financial Exhibit
Financial Exhibit
May 2021
Bylaw Change
Change in Control
Event for Officers
Financial Exhibit
New Agreement
Regulated Disclosure
Unregistered Sales
Change in Control
Event for Officers
Financial Exhibit
New Agreement
Regulated Disclosure
Unregistered Sales
May 2021
Event for Officers
Financial Exhibit
Financial Exhibit
April 2021
Earnings Release
Financial Exhibit
Financial Exhibit
March 2021
Last10K.com | 10-Q Quarterly Report Mon May 15 2017
Document and Entity Information - shares | 3 Months Ended | |
|---|---|---|
Mar. 31, 2017 | May 10, 2017 | |
| Document And Entity Information [Abstract] | ||
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --12-31 | |
| Document Period End Date | Mar. 31, 2017 | |
| Document Fiscal Year Focus | 2017 | |
| Document Fiscal Period Focus | Q1 | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Registrant Name | Aerpio Pharmaceuticals, Inc. | |
| Entity Central Index Key | 0001422142 | |
| Entity Common Stock, Shares Outstanding | 27,075,284 |
View differences made from one quarter to another to evaluate Aerpio Pharmaceuticals, Inc.'s financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aerpio Pharmaceuticals, Inc..
Assess how Aerpio Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy
Aerpio Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Condensed Consolidated Balance Sheets (parenthetical) (unaudited)
Condensed Consolidated Balance Sheets (unaudited)
Condensed Consolidated Statements Of Cash Flows (unaudited)
Condensed Consolidated Statements Of Operations And Comprehensive Loss (unaudited)
Condensed Consolidated Statements Of Stockholders Equity (deficit)
Accounts Payable And Accrued Expenses
Accounts Payable And Accrued Expenses (details)
Accounts Payable And Accrued Expenses (tables)
Commitments And Contingencies
Commitments And Contingencies (detail)
Commitments And Contingencies (tables)
Commitments And Contingencies - Additional Information (detail)
Common Stock
Common Stock - Additional Information (detail)
Employee Stock Purchase Plan
Employee Stock Purchase Plan - Additional Information (detail)
Income Taxes
Income Taxes - Additional Information (detail)
Nature Of Organization And Operations
Nature Of Organization And Operations - Additional Information (detail)
Net Loss Per Share
Net Loss Per Share (detail)
Net Loss Per Share (tables)
Notes Payable To Investors
Notes Payable To Investors - Additional Information (detail)
Preferred Stock
Preferred Stock - Additional Information (detail)
Related-party Arrangements
Related-party Arrangements (detail)
Related-party Arrangements (tables)
Schedule Of Weighted Average Common Stock Equivalents Were Excluded From Calculation Of Diluted Net Loss Per Share (detail)
Stock-based Compensation
Stock-based Compensation (tables)
Stock-based Compensation - 2 (detail)
Stock-based Compensation - 3 (detail)
Stock-based Compensation - 4 (detail)
Stock-based Compensation - Additional Information (detail)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (detail)
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (table)
Summary Of Significant Accounting Policies - Additional Information (detail)
Material Contracts, Statements, Certifications & more
Aerpio Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ARPO
CIK: 1422142
Form Type: 10-Q Quarterly Report
Accession Number: 0001564590-17-011099
Submitted to the SEC: Mon May 15 2017 5:29:05 PM EST
Accepted by the SEC: Mon May 15 2017
Period: Friday, March 31, 2017
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/arpo/0001564590-17-011099.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...